BSE Live
Jun 02, 16:01Prev. Close
639.75
Open Price
641.80
Bid Price (Qty.)
632.95 (1)
Offer Price (Qty.)
641.50 (23)
NSE Live
Jun 02, 15:47Prev. Close
640.55
Open Price
634.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Eris Lifesciences (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 0.00 | 458.54 | 388.89 | 323.59 | 311.78 | |
Net CashFlow From Operating Activities | 0.00 | 369.41 | 395.41 | 265.19 | 216.31 | |
Net Cash Used In Investing Activities | 0.00 | -267.64 | -347.86 | 126.80 | 2.08 | |
Net Cash Used From Financing Activities | 0.00 | -88.42 | -81.13 | -333.52 | -220.74 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 13.36 | -33.58 | 58.47 | -2.34 | |
Cash And Cash Equivalents Begin of Year | 0.00 | 31.35 | 64.93 | 6.46 | 8.81 | |
Cash And Cash Equivalents End Of Year | 0.00 | 44.70 | 31.35 | 64.93 | 6.46 |
17.05.2023
Eris Life Standalone March 2023 Net Sales at Rs 314.58 crore, up 11.5% Y-o-Y
17.05.2023
Eris Life Consolidated March 2023 Net Sales at Rs 402.80 crore, up 31.66% Y-o-Y
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher